Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

370 ARTÍCULOS , VIENDO DEL 76 AL 90

Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead

Kumar D, Ganeshpurkar A, Kumar D, Modi G, Gupta SK, Singh SK.

Eur J Med Chem. 2018 Mar 25;148:436-452. doi: 10.1016/j.ejmech.2018.02.035. Epub 2018 Feb 15.

Memorcise and Alzheimer's disease

Loprinzi PD, Frith E, Ponce P.

Phys Sportsmed. 2018 May;46(2):145-154. doi: 10.1080/00913847.2018.1445932. Epub 2018 Mar 9.

Setbacks in Alzheimer research demand new strategies, not surrender

Jobke B, McBride T, Nevin L, Peiperl L, Ross A, Stone C, Turner R; as the PLOS Medicine Editors.

PLoS Med. 2018 Feb 27;15(2):e1002518. doi: 10.1371/journal.pmed.1002518. eCollection 2018 Feb.

Recent developments with tau-based drug discovery

Iqbal K, Liu F, Gong CX.

Expert Opin Drug Discov. 2018 May;13(5):399-410. doi: 10.1080/17460441.2018.1445084. Epub 2018 Mar 1.

Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment

Gauthier S, Ng KP, Pascoal TA, Zhang H, Rosa-Neto P.

J Alzheimers Dis. 2018;64(s1):S23-S31. doi: 10.3233/JAD-179924.

Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease

Batool A, Kamal MA, Rizvi SMD, Rashid S.

Curr Drug Metab. 2018;19(8):704-713. doi: 10.2174/1389200219666180305152553.

[Nursing home placement of people with dementia: a secondary analysis of qualitative data and literature review on perspectives of informal caregivers and healthcare professionals]

Nguyen N, Renom-Guiteras A, Meyer G, Stephan A.

Pflege. 2018 Jun;31(3):155-166. doi: 10.1024/1012-5302/a000611. Epub 2018 Mar 8.

TNF alpha inhibitors in Alzheimer's disease: A systematic review

Ekert JO, Gould RL, Reynolds G, Howard RJ.

Int J Geriatr Psychiatry. 2018 May;33(5):688-694. doi: 10.1002/gps.4871. Epub 2018 Mar 7.

Alzheimer dementia: Starting, stopping drug therapy

Kim LD, Factora RM.

Cleve Clin J Med. 2018 Mar;85(3):209-214. doi: 10.3949/ccjm.85a.16080.

Editorial: Signaling Molecules as Biomarkers and Therapeutic Targets for Alzheimer's Disease: A New Perspective

Moreno S.

Curr Alzheimer Res. 2018 Feb 22;15(4):302. doi: 10.2174/156720501504180222162435.

Profiling donepezil template into multipotent hybrids with antioxidant properties

Mezeiova E, Spilovska K, Nepovimova E, Gorecki L, Soukup O, Dolezal R, Malinak D, Janockova J, Jun D, Kuca K, Korabecny J.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):583-606. doi: 10.1080/14756366.2018.1443326.

Alzheimer-Demenz – die kognitiven «Enhancer» haben kaum einen positiven Effekt auf den weiteren Verlauf

Steurer J.

Praxis (Bern 1994). 2018;107(6):335-336. doi: 10.1024/1661-8157/a002919.

Combining drug and music therapy in patients with moderate Alzheimer's disease: a randomized study

Giovagnoli AR, Manfredi V, Schifano L, Paterlini C, Parente A, Tagliavini F.

Neurol Sci. 2018 Jun;39(6):1021-1028. doi: 10.1007/s10072-018-3316-3. Epub 2018 Mar 17.

Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease

Chang W, Teng J.

Drug Des Devel Ther. 2018 Mar 5;12:455-462. doi: 10.2147/DDDT.S155567. eCollection 2018.

Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future

Cummings J, Ritter A, Zhong K.

J Alzheimers Dis. 2018;64(s1):S3-S22. doi: 10.3233/JAD-179901.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias